The 10-year rates of local or regional cancer recurrence after BCS, followed by radiation therapy (RT), are about 2-3% for estrogen receptor (ER)-positive and HER-2 positive breast cancers and about 5% for TNBC. This evidence concerns the gene ERBB2 and breast cancer.